Allogeneic Blood or Marrow Transplantation (AlloBMT) with High-Dose Post-Transplantation Cyclophosphamide (PTCy) for Acute Lymphoblastic Leukemia (ALL) in Patients Aged ≥ 55: Best Results in B ALL in First Remission (CR1) with Reduced-Intensity Conditioning (RIC)

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2022-11, Vol.140 (Supplement 1), p.4813-4815
Hauptverfasser:	Webster, Jonathan Allen, Reed, Madison C., Tsai, Hua-Ling, Ambinder, Alexander J., Jain, Tania, DeZern, Amy E., Levis, Mark J., Showel, Margaret M., Prince, Gabrielle T., Hourigan, Christopher S., Bolaños-Meade, Javier, Gondek, Lukasz P., Ghiaur, Gabriel, Dalton, William Brian, Paul, Suman, Fuchs, Ephraim J., Gocke, Christian B., Ali, Abbas Abbas, Gladstone, Douglas E., Huff, Carol Ann, Borrello, Ivan M., Swinnen, Lode J., Wagner-Johnston, Nina D., Ambinder, Richard F., Luznik, Leo, Gojo, Ivana, Smith, B. Douglas Douglas, Varadhan, Ravi, Jones, Richard J., Imus, Philip H.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!